Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intravenous administration of PGF-2 alpha or an analogue stimulated uterine contractility in gravid uteri during seasonal quiescence and late pregnancy. The exogenous PGF-2 alpha was metabolized to 13,14-dihydro-15-keto-PGF-2 alpha (PGFM) which was assayed in peripheral plasma by a radioimmunoassay. PGFM was cleared from the circulation with a half life of 8-15 min. Blood samples were taken approximately every 6 h from Day 26 to Day 30 from tammars which were expected to give birth on Day 27-28. Basal levels of PGFM were less than 400 pg/ml, and only occasional samples contained higher PGFM concentrations. Therefore, if uterine PGF-2 alpha release is elevated at parturition in tammars, the corresponding rise of circulating PGFM is either small or of short duration.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on